|
|
|
| Biodegradation of Electrospun Poly (Llactic acidcoεcaprolactone)/Collagen Composite Vascular Grafts |
1 Department of Vascular Surgery, Sixth People’s Hospital of Shanghai, Shanghai 200233, China
2 Biomaterials and Tissue Engineering Laboratory, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, China |
|
|
|
Abstract To evaluate the biodegradation and biocompatibility of poly (Llactic acidcoεcaprolactone) (P(LLACL))/collagen graft, P (LLACL) collagen graft scaffolds were made through electrospinning. The prepared scaffolds were set as experimental group (n=40) and the commercial artificial vessel made
of ePTFE was set as control group (n=40). The scaffold samples were implanted in the left dorsal muscle of rabbits, while ePTFE graft materials were implanted in the opposite side. On day 10, 30, 90 and 180 after the implantation, the samples were harvested. The histological staining was applied to observe the degradation of the material and tissue reaction. The number of neutrophils, macrophages and lymphocytes were counted at the high magnification (400×) using the optical microscope. Under the microscope, slight tissue reaction was revealed in the area of P (LLACL)/collagen material. On day 90, the material broken was observed. Some connective fibrous tissue was revealed in the material, a capsulelike membrane was established over the area. During the process of degradation, most of the materials were absorbed within 180 days. The structure and distribution of the tissue cells was highly similar to that of the surrounding area, indicating that the remodeling of the embedded tissue was almost finished. The ePTFE materials were revealed still maintaining the structure encompassed in a thin layer of fibrous connective tissue. The result of cell count showed that the type and trend of cell reaction had no difference after the different stages of postoperation. However, the count of neutrophile granulocyte in experimental group was more than that in the control group on day 10 (2244±372 vs 1922±181 /025 mm2, P<005), while no difference of various types of cells was observed between the two groups post operation. The degeneration of P (LLACL)/collagen material was 90-180 days, which is a satisfying biological performance in the degradation and biocompatibility.
|
|
|
|
|
|
［1］刘晓锋，莫秀梅，何创龙，等. 聚酯酰胺静电纺纳米纤维膜的制备及其生物相容性［J］.中国组织工程研究与临床康复, 2009, 13(51):10045-10048.
［2］陈锐，柯勤飞，莫秀梅，等. 组织工程心脏瓣膜:结构及支架的研究与进展［J］. 中国组织工程研究与临床康复, 2008, 12(23):4497-4502.
［3］邱立军，王红声，莫秀梅,等. 聚（左旋乳酸-己内酯）/Fe3O4取向超细纤维的制备及生物相容性［J］. 中国组织工程研究与临床康复，2009, 13(12):2222-2226.
［4］Sun Xiangying, Wu Linbo. Synthesis and properties of crystalline dicarboxylated poly(Llactic acid) prepolymers［J］. Journal of Applied Polymer Science, 2011, 121(6):3246-3251.
［5］Chang Haibo, Zhang Jianming, Li Li, et al. A study on the epitaxial ordering process of the polycaprolactone on the highly oriented polyethylene substrate ［J］.Macromolecules, 2010, 43(1):362-366.
［6］张建松，张鹏云，徐晓红，等. 两种聚（左旋乳酸-己内酯）静电纺纳米纤维膜的性能比较.中国组织工程研究与临床康复.2009,13(8):1500-1504.
［7］Sell SA, McClure MJ, Garg K, et al. Electrospinning of collagen/ biopolymers for regenerative medicine and cardiovascular tissue engineering［J］.Adv Drug Deliv Rev,2009，61(12):1007-1019.
［8］Huang Chen, Chen Rui, Mo Xiumei, et al. Electrospun collagenchitosanTPU nanofibrous scaffolds for tissue engineered tubular grafts ［J］. Colloids Surf B Biointerfaces,2011, 82(2):307-315..
［9］Mo Xiumei，Weber HJ, Teoh SH. A Biodegradable tubular scaffold fabrication and fibroblast cells culture in vitro ［J］. The International Journal of Artificial Organs, 2006, 29(8):790-799.
［10］Mo Xiumei, Weber HJ，Bhuju S, et al. Investigation of biodegradable nanofibers in tubular scaffolds for tissue regeneration ［J］. Journal of Medical Biomechanics, 2005, 20:90-91.
［11］莫秀梅, 吴晶磊. 胶原蛋白/乳酸-己内酯共聚物复合纤维支架的制备方法: 中国, 201310098520 ［P］. 2013-3-25.
［12］Yin Anlin, Zhang Kuihua, McClure Michael J, et al. Electrospinning collagen/ chitosan/poly (Llactic acidco-ε-caprolactone ) to form a vascular graft: Mechanical and biological characterization［J］. J Biomed Mater Res A, 2013, 101(5):1292-1301.
［13］The Ministry of Science and Technology of the People’s Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
［14］任杰.可降解与吸收材料. 北京:化学工业出版社，2002: 232.
［15］Freyria AM, Ronziere MC, Cortial D, et al. Comparative phenotypic analysis of articular chondrocytes cultured within type Ⅰ or type Ⅱ collagen scaffolds ［J］. Tissue Eng Part A, 2009, 15(6):1233-1245
［16］Stack RS, Califf RM, Phillips HR, et al. Interventional cardiac catheterization at Duke medical center ［J］.Am J Cardiol, 1988, 62(10 Pt2):3F-24F.
［17］Prockop DJ, Kivirikko KI. Collagens: molecular biology, diseases, and potentials for therapy ［J］. Annu Rev Biochem, 1995, 64:403-434.
［18］Gunatillake PA, Adhikari R.Biodegradable synthetic polymers for tissue engineering ［J］. Eur Cell Mater, 2003, 20(5):1-16.
［19］Kim JK, Park DJ, Lee MS, et al. Synthesis and crystallization behavior of poly (Llactide)blockpoly (εcaprolactone) copolymer ［J］. Polymer,2001,42(17):7429-7441.
［20］Mo Xiu mei， Xu CY， Kotaki M，et al. Electrospun P (LLACL) nanofiber: a biomimetic extracelluer matrix for smooth muscle cell and endothelial cell proliferation ［J］. Biomaterials, 2004, [STHZ]25[STBZ](10):1883-1890.
［21］Soletti L, Hong Y, Guan J, et al. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts ［J］. Acta Biomater, 2010, 6(1):110-122.
［22］Clarke KI, Graves S E, Wong ATC, et al. Investigation into the formation and mechanical properties of a bioactive material based on collagen and calcium phosphate ［J］.J Mater Sci Med, 1993,4: 107-111.
［23］Yang HM, Lee HJ, Park CW, et al. Endosomeescapable magnetic poly (amino acid) nanoparticles for cancer diagnosis and therapy ［J］. Chem Commun, 2011, 47(18):5322-5324.
［24］Kim BS, Mooney DJ. Development of biocompatible synthetic extra cellular matrices for tissue engineering ［J］.Trends Biotechnol,1998,16(5):224-226.
［25］钱永芳，莫秀梅，柯勤飞,等.静电纺纳米纤维用于组织工程支架［J］.中国组织工程与康复杂志,2007,11(22):4371-4375.
|
|
|
|
